Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
cls
-
search results
If you're not happy with the results, please do another search
CLS’ partner initiates full market release in the US
5 June, 2024
CLS revises strategy – increases focus on neurosurgery
24 May, 2024
CLS launches in France
15 May, 2024
CLS makes progress in prostate cancer in Europe and the US
12 April, 2024
Publication in Journal of Neurosurgery demonstrates the benefits of CLS’ technology
19 March, 2024
CLS sees opportunity to increase revenue
1 March, 2024
U.S. biotechs raise more capital
20 February, 2024
Breakthrough in the Asia-Pacific region for CLS
16 January, 2024
CLS receives order from ClearPoint Neuro
9 January, 2024
CLS initiates new prostate cancer study in France
5 December, 2023
CLS strengthens its position in the US
30 November, 2023
CLS looks forward to further expansion
21 November, 2023
CLS starts new clinical study in prostate cancer
9 November, 2023
CLS CEO on Q2 and upcoming milestones
28 August, 2023
CFO about CLS’ aims
1 March, 2023
Progress with a new gene therapy in severe skin disease
22 December, 2022
Watch the BioStock Life Science Fall Summit!
8 December, 2022
CombiGene’s CEO on the FDA approval of Hemgenix
1 December, 2022
Swedish innovations in the fight against prostate cancer
28 November, 2022
CLS on a Q3 characterised by US-advancement
23 November, 2022
ClearPoint Neuro delivers first order to CLS
21 October, 2022
BioStock Studio: CLS about the FDA clearance
3 October, 2022
BioStock Life Science Fall Summit 2022
16 August, 2022
Accelerated clinical trials and launch of new products for CLS
4 August, 2022
Watch day 2 of the BioStock Life Science Spring Summit
9 June, 2022
The BioStock Life Science Spring Summit starts now
8 June, 2022
BioStock Life Science Spring Summit, June 8-9, 2022
26 March, 2022
CLS enters 2022 raring to go
18 January, 2022
CLS re-releases sterile disposable instruments on the European market
2 December, 2021
BioStock Studio: CLS’ CEO about Q3 and the road ahead
22 November, 2021
Promising results from clinical study with CLS product
14 October, 2021
BioStock Studio: CLS’ CEO and VP Clinical Affairs on Q2
25 August, 2021
CLS resumes clinical study in prostate cancer
14 July, 2021
CLS increases focus on clinical studies and strategic collaborations
9 July, 2021
CLS’s development is on track
6 July, 2021
German university hospital evaluates CLS’s product
5 July, 2021
CLS erhåller ny order från Tyskland
5 July, 2021
CLS updates time plan regarding FDA application for Thermoguide
5 July, 2021
CLS strengthens the board with three experienced members
4 July, 2021
CLS granted patent in Japan
4 July, 2021
CLS and University Hospital Magdeburg enhances the collaboration and conducts clinical...
3 July, 2021
CLS sets the direction for 2021 with clinical and commercial focus...
2 July, 2021
CLS’s rights issue oversubscribed
1 July, 2021
CLS’ partner hospital gets the go-ahead for prostate cancer study
29 June, 2021
BioStock Studio: CLS on the focus for 2021, milestones and the...
3 March, 2021
CLS strengthens organisation prior to global establishment
4 February, 2021
BLSS 2019 videos: both bio- and medtech on display in third...
31 October, 2019
